OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Dow Jones Futures Rise, Big News For Merck; Tesla, Apple Lead 7 Stocks Near Buy Points

April 16, 2023

Tesla and Netflix are near buy points with earnings due in a volatile market rally. Apple and Lululemon have tight entries. Read More...

3rdPartyFeeds • News

: Klobuchar calls for Supreme Court ethics rules amid new questions over Clarence Thomas’s income

April 16, 2023

Sen. Amy Klobuchar called for "clear and enforceable" ethics rules for Supreme Court justices Sunday, as a new report found Justice Clarence Thomas has for...

3rdPartyFeeds

Dow Jones Futures Rise: Tesla, Apple Lead 7 Stocks Near Buy Points In Tricky Market Rally

April 16, 2023

Tesla and Netflix are near buy points with earnings due in a volatile market rally. Apple and Lululemon have tight entries. Read More...

3rdPartyFeeds

Will Amazon Prime Get More Expensive in 2023?

April 16, 2023

An annual Prime membership costs $139 a year. Read on to see if that number is likely to climb this year. Read More...

3rdPartyFeeds • News

: Moderna, Merck combo cancer-vaccine treatment shows ‘significant’ promise

April 16, 2023

A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 44%...

3rdPartyFeeds • News

: Merck to buy Prometheus Biosciences for $10.8 billion

April 16, 2023

Merck & Co. Inc. announced Sunday a deal to acquire Prometheus Biosciences Inc. for $200 a share, or about $10.8 billion. Read More...

3rdPartyFeeds

Dow Jones Futures Loom: Tesla, Apple Lead 7 Stocks Near Buy Points In Market Rally

April 16, 2023

Tesla and Netflix are near buy points with earnings due in a volatile market rally. Apple and Lululemon have tight entries. Read More...

3rdPartyFeeds

Tesla, AT&T, Goldman Sachs, Netflix, Charles Schwab, and More Stocks to Watch This Week

April 16, 2023

First-quarter earnings season picks up with results from Charles Schwab, Bank of America, Goldman Sachs, Johnson & Johnson, Netflix, IBM, Tesla, and AT...

3rdPartyFeeds

Google scrambles for new search engine as AI creeps in: report

April 16, 2023

Google is reportedly working on adding artificial intelligence features to its search engine while simultaneously building a new search engine powered by AI...

3rdPartyFeeds • News

The Escape Home: Everything you need to know as a first-time homebuyer

April 16, 2023

Purchasing a home — especially in this market — can seem like a daunting task. Read More...

Previous 1 … 1,235 1,236 1,237 1,238 1,239 … 8,455 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.